Discover the new CAR T-cell therapy that offers hope for multiple myeloma treatment making it affordable and accessible in ...

(HealthDay News) — Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted ...

July 24, 2024 — A simple blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether people who have relapsed multiple myeloma are going to ...

The Johnson & Johnson drug Darzalex showed promise in helping keep a precancerous condition from progressing to the blood ...

"CAR T-cell therapy is a one time treatment that we know can have very deep and durable responses for patients," hematologist ...

AIIMS researchers claim to have made significant progress in developing chimeric antigen receptor (CAR) T-cell therapy, ...

Doctors at AIIMS, Delhi are in the process of developing a low-cost antibody-based adaptive cellular therapy for treatment of ...

For patients with functional high-risk multiple myeloma, timely referral to specialized centers is needed, since access to ...

Doctors at AIIMS, Delhi are in the process of developing a low cost antibody-based adaptive cellular therapy for treatment of ...

During a Case-Based Roundtable® event, Hira Shaikh, MD, and participants discussed how they would treat a patient with ...